Effort angina in a middle-aged woman with abnormally high levels of serum high-density lipoprotein cholesterol: A case of cholesteryl-ester transfer protein deficiency

Circulation Journal

Volumn 69, Issue 5, 2005, Pages 609-612

  Nagano, Masahide ^a   Nakamura, Motoyuki ^a   Kobayashi, Noboru ^a   Kamata, Junya ^b   Hiramori, Katsuhiko ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b Ohdori Kamata Clinic   (Japan)

Author keywords

Cholesteryl ester transfer protein; Coronary artery disease; High density lipoprotein cholesterol (HDL C); Probucol

Indexed keywords

ACETYLSALICYLIC ACID; BISOPROLOL FUMARATE; CHOLESTEROL ESTER TRANSFER PROTEIN; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICORANDIL; PRAVASTATIN; PROBUCOL;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERY CALCIFICATION; ARTICLE; CASE REPORT; CHOLESTEROL ESTER TRANSFER PROTEIN DEFICIENCY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; ELECTROCARDIOGRAM; ELECTRON BEAM TOMOGRAPHY; FEMALE; GENE MUTATION; HUMAN; HYPERCHOLESTEROLEMIA; PROTEIN DEFICIENCY; RIGHT CORONARY ARTERY; THORAX PAIN; TREADMILL EXERCISE;

ANGINA PECTORIS; ANTICHOLESTEREMIC AGENTS; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; FEMALE; GLYCOPROTEINS; HUMANS; MIDDLE AGED; MUTATION; PROBUCOL;

EID: 19744363610     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.69.609     Document Type: Article

References (19)

1. Brown ML, Inazu A, Hesler CB, Agellon LB, Mann C, Whitlock ME, et al. Molecular basis of lipid transfer protein deficiency in a family with increased high density lipoproteins. Nature 1989; 342: 448-451.
2. Yamashita S, Ishigami M, Arai T, Sakai N, Hirano K, Kameda-Takemura K, et al. Very high density lipoproteins induced by plasma cholesteryl ester transfer protein (CETP) have a potent antiatherogenic function. Ann NY Acad Sci USA 1995; 748: 606-608.
3. Hirano K, Yamashita S, Nakajima N, Arai T, Maruyama T, Yoshida Y, et al. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Arterioscler Thromb Vasc Biol 1997; 17: 1053-1059.
4. Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996; 97: 2917-2923.
5. Tenkanen H, Koshinen P, Kontula K, Aalto-Setala K, Manttari M, Manninen V, et al. Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet 1991; 87: 574-578.
6. Assmann G, Eckardstein AV, Funke H. High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Circulation 1993; 87(Suppl III): 28-34.
7. Matsuzawa Y, Yamashita S, Funahashi T, Yamamoto A, Tarui S. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer. Am J Cardiol 1988; 62: 66B-72B.
8. Adlouni A, Messal ME, Saile R, Parra H, Fruchart J, Ghalim N. Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia: Effects on apolipoprotein AI-containing lipoprotein particles. Atherosclerosis 2000; 152: 433-440.
9. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 1196-1204.
10. Hirano K, Matsuzawa Y, Sakai N, Hiraoka H, Nozaki S, Funahashi T, et al. Polydisperse low density lipoproteins hyperalphalipoproteinemic chronic alcohol drinkers in association with marked reduction of cholesteryl ester transfer activity. Metabolism 1992; 41: 1313-1318.
11. Weitzman JB, Vladutiu AO. Very high values of serum high-density lipoprotein cholesterol. Arch Pathol Lab Med 1992; 116: 831-836.
12. Maruyama T, Sakai N, Ishigami M, Hirano K, Arai T, Okada S, et al. Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia. Atherosclerosis 2003; 166: 177-185.
13. Yamashita S, Matsuzawa Y, Okazaki M, Kako H, Yasugi T, Akioka H, et al. Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity. Atherosclerosis 1988; 70: 7-12.
14. Tangirala RK, Jerome WG, Jones NL, Small DM, Johnson WJ, Glick JM, et al. Formation of cholesterol monohydrate crystals in macrophage-derived foam cells. J Lipid Res 1994; 35: 93-104.
15. Sakai N, Yamashita S, Hirano K, Ishigami M, Arai T, Kobayashi K, et al. Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency. Eur J Clin Invest 1995; 25: 332-339.
16. Chiesa G, Michelagnoli S, Cassinotti M, Gianfranceschi G, Werba JP, Pazzucconi F, et al. Mechanisms of high-density lipoprotein reduction after probucol treatment. Metabolism 1993; 42: 229-235.
17. Ishigami M, Yamashita S, Sakai N, Hirano K, Arai T, Maruyama T, et al. High-density lipoproteins from probucol-treated patients have increased capacity to promote cholesterol efflux from mouse peritoneal macrophages with acetylated low-density lipoproteins. Eur J Clin Invest 1997; 27: 285-292.
18. Rinninger F, Wang N, Ramakrishnan R, Jiang XC, Tall AR. Probucol enhances selective uptake of HDL-associated cholesteryl esters in vitro by a scavenger receptor B1-dependent mechanism. Arteriosder Thromb Vasc Biol 1999; 19: 1325-1332.
19. Noto H, Kawamura M, Hashimoto Y, Satoh H, Hara M, Iso-o N, et al. Modulation of HDL metabolism by probucol in complete cholesteryl ester transfer protein deficiency. Atherosclerosis 2003; 171: 131-136.